- Home
- PLUR vs IXHL Comparison
PLUR vs IXHL Comparison
Compare PLUR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- IXHL
- Stock Information
- Founded
- PLUR 2001
- IXHL 2001
- Country
- PLUR Israel
- IXHL Australia
- Employees
- PLUR N/A
- IXHL N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- IXHL
- Sector
- PLUR Health Care
- IXHL
- Exchange
- PLUR Nasdaq
- IXHL Nasdaq
- Market Cap
- PLUR 30.2M
- IXHL 28.7M
- IPO Year
- PLUR N/A
- IXHL N/A
- Fundamental
- Price
- PLUR $4.81
- IXHL $2.08
- Analyst Decision
- PLUR
- IXHL
- Analyst Count
- PLUR 0
- IXHL 0
- Target Price
- PLUR N/A
- IXHL N/A
- AVG Volume (30 Days)
- PLUR 16.4K
- IXHL 25.0K
- Earning Date
- PLUR 11-11-2024
- IXHL 09-30-2024
- Dividend Yield
- PLUR N/A
- IXHL N/A
- EPS Growth
- PLUR N/A
- IXHL N/A
- EPS
- PLUR N/A
- IXHL N/A
- Revenue
- PLUR $326,000.00
- IXHL $12,000.00
- Revenue This Year
- PLUR N/A
- IXHL N/A
- Revenue Next Year
- PLUR N/A
- IXHL N/A
- P/E Ratio
- PLUR N/A
- IXHL N/A
- Revenue Growth
- PLUR 13.59
- IXHL N/A
- 52 Week Low
- PLUR $3.44
- IXHL $0.80
- 52 Week High
- PLUR $8.48
- IXHL $12.68
- Technical
- Relative Strength Index (RSI)
- PLUR 42.15
- IXHL 65.77
- Support Level
- PLUR $4.52
- IXHL $1.52
- Resistance Level
- PLUR $5.34
- IXHL $1.93
- Average True Range (ATR)
- PLUR 0.40
- IXHL 0.09
- MACD
- PLUR -0.06
- IXHL 0.03
- Stochastic Oscillator
- PLUR 17.40
- IXHL 100.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.